About this data
What it is
When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
Who files it
The insider, usually through the company, within two business days of the trade.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.

All of this comes from public filings.

Open-market trades per day, last 30 days

05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0
05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0

Purchases Sales

By trade date. Insiders have two business days to file, so the most recent days fill in later.

Latest open-market insider trades

Reset

Showing: ticker EW

Latest open-market insider trades
TradedInsiderCompanyTypeSharesPriceValueFiling
Nov 10, 2026Daniel J. Lippis
CVP, TAVR
EW
Edwards Lifesciences Corporation
Sale619$104.25$64.5K SaleForm 4 ↗
Nov 9, 2026Bernard J. Zovighian
CEO, Director
EW
Edwards Lifesciences Corporation
Sale13,916$102.78$1.4M SaleForm 4 ↗
Nov 9, 2026Bernard J. Zovighian
CEO, Director
EW
Edwards Lifesciences Corporation
Sale9,184$103.39$949.5K SaleForm 4 ↗
Nov 9, 2026Donald E. Bobo Jr.
CVP,Strategy/Corp Development
EW
Edwards Lifesciences Corporation
Sale48,900$103.05$5.0M SaleForm 4 ↗
Sep 11, 2026Daniel J. Lippis
CVP, TAVR
EW
Edwards Lifesciences Corporation
Sale619$87.51$54.2K SaleForm 4 ↗
Aug 31, 2026Andrew M. Dahl
SVP, Corporate Controller
EW
Edwards Lifesciences Corporation
Sale544$91.06$49.5K SaleForm 4 ↗
Aug 28, 2026Annette Bruls
CVP, EMEACLA
EW
Edwards Lifesciences Corporation
Sale2,644$89.98$237.9K SaleForm 4 ↗
Aug 26, 2026Daveen Chopra
CVP, TMTT, Surgical & IHFM
EW
Edwards Lifesciences Corporation
Sale30,646$90.99$2.8M SaleForm 4 ↗
Aug 26, 2026Daveen Chopra
CVP, TMTT, Surgical & IHFM
EW
Edwards Lifesciences Corporation
Sale1,154$91.76$105.9K SaleForm 4 ↗
Aug 26, 2026Wayne Markowitz
CVP, JAPAC
EW
Edwards Lifesciences Corporation
Sale1,240$91.47$113.4K SaleForm 4 ↗
Aug 11, 2026Daniel J. Lippis
CVP, TAVR
EW
Edwards Lifesciences Corporation
Sale619$92.03$57.0K SaleForm 4 ↗
Jul 30, 2026Wayne Markowitz
CVP, JAPAC
EW
Edwards Lifesciences Corporation
Sale146$86.03$12.6K SaleForm 4 ↗
Jul 28, 2026Wayne Markowitz
CVP, JAPAC
EW
Edwards Lifesciences Corporation
Sale9,628$85.06$819.0K SaleForm 4 ↗
Jul 27, 2026Bernard J. Zovighian
CEO, Director
EW
Edwards Lifesciences Corporation
Sale2,921$83.93$245.1K SaleForm 4 ↗
Jul 10, 2026Daniel J. Lippis
CVP, TAVR
EW
Edwards Lifesciences Corporation
Sale619$91.70$56.8K SaleForm 4 ↗
Jun 30, 2026Daniel J. Lippis
CVP, TAVR
EW
Edwards Lifesciences Corporation
Sale619$91.40$56.6K SaleForm 4 ↗
Jun 17, 2026Bernard J. Zovighian
CEO, Director
EW
Edwards Lifesciences Corporation
Sale523$87.92$46.0K SaleForm 4 ↗
May 29, 2026Andrew M. Dahl
SVP, Corporate Controller
EW
Edwards Lifesciences Corporation
Sale568$86.08$48.9K SaleForm 4 ↗
May 27, 2026Donald E. Bobo Jr.
CVP,Strategy/Corp Development
EW
Edwards Lifesciences Corporation
Sale23,145$86.42$2.0M SaleForm 4 ↗
May 22, 2026Daveen Chopra
CVP, TMTT & Surgical
EW
Edwards Lifesciences Corporation
Sale1,500$84.60$126.9K SaleForm 4 ↗
May 18, 2026Daniel J. Lippis
CVP, TAVR
EW
Edwards Lifesciences Corporation
Sale620$81.14$50.3K SaleForm 4 ↗
May 15, 2026Donald E. Bobo Jr.
CVP,Strategy/Corp Development
EW
Edwards Lifesciences Corporation
Sale8,000$81.82$654.6K SaleForm 4 ↗
May 15, 2026Donald E. Bobo Jr.
CVP,Strategy/Corp Development
EW
Edwards Lifesciences Corporation
Sale9,968$82.07$818.1K SaleForm 4 ↗
May 12, 2026Bernard J. Zovighian
CEO, Director
EW
Edwards Lifesciences Corporation
Sale35,506$77.92$2.8M SaleForm 4 ↗
May 12, 2026Bernard J. Zovighian
CEO, Director
EW
Edwards Lifesciences Corporation
Sale845$78.40$66.2K SaleForm 4 ↗
May 11, 2026Wayne Markowitz
CVP, JAPAC
EW
Edwards Lifesciences Corporation
Sale593$79.73$47.3K SaleForm 4 ↗
May 4, 2026Daniel J. Lippis
CVP, TAVR
EW
Edwards Lifesciences Corporation
Sale1,019$83.98$85.6K SaleForm 4 ↗
May 1, 2026Daniel J. Lippis
CVP, TAVR
EW
Edwards Lifesciences Corporation
Sale1,000$82.99$83.0K SaleForm 4 ↗
May 1, 2026Daniel J. Lippis
CVP, TAVR
EW
Edwards Lifesciences Corporation
Sale19$83.99$1,596 SaleForm 4 ↗
Apr 9, 2026Scott B. Ullem
CVP, Chief Financial Officer
EW
Edwards Lifesciences Corporation
Sale8,324$79.79$664.2K SaleForm 4 ↗
Apr 9, 2026Scott B. Ullem
CVP, Chief Financial Officer
EW
Edwards Lifesciences Corporation
Sale4,676$80.50$376.4K SaleForm 4 ↗
Apr 6, 2026Daniel J. Lippis
CVP, TAVR
EW
Edwards Lifesciences Corporation
Sale1,019$80.98$82.5K SaleForm 4 ↗
Apr 2, 2026Donald E. Bobo Jr.
CVP,Strategy/Corp Development
EW
Edwards Lifesciences Corporation
Sale18,004$80.05$1.4M SaleForm 4 ↗
Apr 2, 2026Donald E. Bobo Jr.
CVP,Strategy/Corp Development
EW
Edwards Lifesciences Corporation
Sale4,676$80.59$376.8K SaleForm 4 ↗
Mar 11, 2026Scott B. Ullem
CVP, Chief Financial Officer
EW
Edwards Lifesciences Corporation
Sale7,901$85.21$673.2K SaleForm 4 ↗
Mar 11, 2026Scott B. Ullem
CVP, Chief Financial Officer
EW
Edwards Lifesciences Corporation
Sale5,099$84.46$430.7K SaleForm 4 ↗
Mar 11, 2026Daniel J. Lippis
CVP, TAVR
EW
Edwards Lifesciences Corporation
Sale1,019$85.38$87.0K SaleForm 4 ↗
Mar 2, 2026Donald E. Bobo Jr.
CVP,Strategy/Corp Development
EW
Edwards Lifesciences Corporation
Sale11,340$85.93$974.4K SaleForm 4 ↗
Feb 25, 2026Donald E. Bobo Jr.
CVP,Strategy/Corp Development
EW
Edwards Lifesciences Corporation
Sale24,000$83.84$2.0M SaleForm 4 ↗
Feb 12, 2026Bernard J. Zovighian
CEO, Director
EW
Edwards Lifesciences Corporation
Sale19,898$76.61$1.5M SaleForm 4 ↗
Feb 12, 2026Bernard J. Zovighian
CEO, Director
EW
Edwards Lifesciences Corporation
Sale2,532$77.13$195.3K SaleForm 4 ↗
Jan 9, 2026Daniel J. Lippis
CVP, TAVR
EW
Edwards Lifesciences Corporation
Sale1,019$85.70$87.3K SaleForm 4 ↗
Jan 6, 2026Donald E. Bobo Jr.
CVP,Strategy/Corp Development
EW
Edwards Lifesciences Corporation
Sale8,708$85.98$748.7K SaleForm 4 ↗
Jan 6, 2026Donald E. Bobo Jr.
CVP,Strategy/Corp Development
EW
Edwards Lifesciences Corporation
Sale2,632$84.62$222.7K SaleForm 4 ↗
Dec 12, 2025Donald E. Bobo Jr.
CVP,Strategy/Corp Development
EW
Edwards Lifesciences Corporation
Sale5,900$83.74$494.1K SaleForm 4 ↗
Dec 12, 2025Donald E. Bobo Jr.
CVP,Strategy/Corp Development
EW
Edwards Lifesciences Corporation
Sale5,486$83.79$459.7K SaleForm 4 ↗
Dec 12, 2025Daniel J. Lippis
CVP, JAPAC
EW
Edwards Lifesciences Corporation
Sale1,019$84.03$85.6K SaleForm 4 ↗
Dec 12, 2025Heisz Leslie Stone
Director
EW
Edwards Lifesciences Corporation
Sale2,615$83.41$218.1K SaleForm 4 ↗
Dec 11, 2025Daveen Chopra
CVP, TMTT & Surgical
EW
Edwards Lifesciences Corporation
Sale2,000$84.38$168.8K SaleForm 4 ↗
Dec 10, 2025Donald E. Bobo Jr.
CVP,Strategy/Corp Development
EW
Edwards Lifesciences Corporation
Sale11,340$83.83$950.6K SaleForm 4 ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:38 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances